Trastuzumab emtansine (T-DM1) in patients with previously treated HER2-overexpressing metastatic non–small cell lung cancer: Efficacy, safety, and biomarkers

  1. Peters, S.
  2. Stahel, R.
  3. Bubendorf, L.
  4. Bonomi, P.
  5. Villegas, A.
  6. Kowalski, D.M.
  7. Baik, C.S.
  8. Isla, D.
  9. De Castro Carpeno, J.
  10. Garrido, P.
  11. Rittmeyer, A.
  12. Tiseo, M.
  13. Meyenberg, C.
  14. de Haas, S.
  15. Lam, L.H.
  16. Lu, M.W.
  17. Stinchcombe, T.E.
Revue:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Année de publication: 2019

Volumen: 25

Número: 1

Pages: 64-72

Type: Article

DOI: 10.1158/1078-0432.CCR-18-1590 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus